OncoCyte Corp Key Opinion Leader Presentation Part 1: Transplant Rejection Testing Transcript
Presentation Part 1: Transplant Rejection Testing
Sep 22, 2021 / 05:00PM GMT
=====================
Corporate Participants
=====================
* Ronald A. Andrews
OncoCyte Corporation - CEO, President & Director
* Sara Riordan
OncoCyte Corporation - Director of Medical Education
=====================
Conference Call Participants
=====================
* Bruce David Jackson
The Benchmark Company, LLC, Research Division - Senior Equity Analyst
* Mark Anthony Massaro
BTIG, LLC, Research Division - MD & Life Science & Diagnostic Tools Analyst
* Michael Stephen Matson
Needham & Company, LLC, Research Division - Senior Analyst
* Thomas Flaten
Lake Street Capital Markets, LLC, Research Division - Senior Research Analyst
* Ekkehard Schuetz
* Michael Oellerich
=====================
-
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |